Roche secures Zealand pharma’s obesity drug in $5.3 billion deal
HQ Team March 12, 2025: Swiss pharmaceutical giant Roche has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma to
HQ Team March 12, 2025: Swiss pharmaceutical giant Roche has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma to
HQ Team March 11, 2025: A recent World Air Quality Report 2024 by Swiss air quality technology company IQAir, has highlighted that 13
HQ Team March 11, 2025: A recent study conducted by the University of Eastern Finland and Kuopio University Hospital has shown that an
HQ Team March 10, 2025: A recent study published in The BMJ forecasts a significant rise in Parkinson’s disease cases globally, with projections
HQ Team March 10, 2025: Patient screening in primary care settings can detect up to 10% of cancers caused by genes. Easily available
HQ Team March 8, 2025: A study published in The Lancet by the Global Burden of Disease Study BMI Collaborators reveals alarming statistics
HQ Team March 8, 2025: A study by the World Health Organization (WHO), Global and Regional Causes of Maternal Deaths 2009–2020, has identified severe
HQ Team March 7, 2025: Johnson & Johnson is discontinuing the Phase 3 VENTURA clinical trial of its experimental depression drug aticaprant after
HQ Times March 7, 2025: A report by Carbon Majors has Coal India listed second among 36 fossil fuel companies responsible for half